ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression

Yao, Bing; Zhu, Sha; Wei, Xiyi; Chen, Ming-Kun; Feng, Yangkun; Li, Zhimin; Xu, Xinyu; Zhang, Yuwei; Wang, Yang; Zhou, Jingwan; Tang, Ningyuan; Ji, Chengjian; Jiang, Peng; Zhao, Shan-Chao*; Qin, Chao*; Feng, Ninghan*南方医科大学; 南通大学; 1
Molecular Cancer2022-5-27DOI: 10.1186/s12943-022-01598-6
12被引6阅读
引用收藏
分享

摘要

Background Prostate cancer (PCa) is the most frequently diagnosed malignancy in men, and its mechanism remains poorly understood. Therefore, it is urgent to discover potential novel diagnostic biomarkers and therapeutic targets that can potentially facilitate the development of efficient anticancer strategies. Methods A series of functional in vitro and in vivo experiments were conducted to evaluate the biological behaviors of PCa cells. RNA pulldown, Western blot, luciferase reporter, immunohistochemistry and chromatin immunoprecipitation assays were applied to dissect the detailed underlying mechanisms. High-throughput sequencing was performed to screen for differentially expressed circRNAs in PCa and adjacent normal tissues. Results Upregulation of protein arginine methyltransferase 5 (PRMT5) is associated with poor progression-free survival and the activation of multiple signaling pathways in PCa. PRMT5 inhibits the transcription of CAMK2N1 by depositing the repressive histone marks H4R3me2s and H3R8me2s on the proximal promoter region of CAMK2N1, and results in malignant progression of PCa both in vitro and in vivo. Moreover, the expression of circSPON2, a candidate circRNA in PCa tissues identified by RNA-seq, was found to be associated with poor clinical outcomes in PCa patients. Further results showed that circSPON2 induced PCa cell proliferation and migration, and that the circSPON2-induced effects were counteracted by miR-331-3p. Particularly, circSPON2 acted as a competitive endogenous RNA (ceRNA) of miR-331-3p to attenuate the repressive effects of miR-331-3p on its downstream target PRMT5. Conclusions Our findings showed that the epigenetic regulator PRMT5 aggravates PCa progression by inhibiting the transcription of CAMK2N1 and is modulated by the circSPON2/miR-331-3p axis, which may serve as a potential therapeutic target for patients with aggressive PCa.

学科与关键词

关键词
PRMT5circSPON2miR-331-3pProstate cancer
相关
加载中…
  • Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p
    Yu, Yu-Zhong; Lv, Dao-Jun; Wang, Chong; Song, Xian-Lu; Xie, Tao; Wang, Tao; Li, Zhi-Min; Guo, Jia-Ding; Fu, Du-Jiang; Li, Kang-Jin; Wu, Ding-Lan; Chan, Franky Leung; Feng, Ning-Han*; Chen, Zhe-Sheng*; Zhao, Shan-Chao*Molecular Cancer, 2022, 21(1): 12.被引 57
  • Inhibitory role of circRNA_100395 in the proliferation and metastasis of prostate cancer cells
    He, Haitian; Li, Jianhua; Luo, Mayao; Wei, Qiang*Journal of International Medical Research, 2021, 49(2): 0300060521992215.被引 7
  • Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis
    Chen, Wenbin; Cen, Shengren; Zhou, Xumin; Yang, Taowei; Wu, Kaihui; Zou, Libin; Luo, Junqi; Li, Chuanyin*; Lv, Daojun*; Mao, Xiangming*Frontiers in Cell and Developmental Biology, 2021, 8: 624764.被引 38
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Cancer
发表日期
2022-05-27
卷期
第 21 卷, 第 1 期
页码
119
DOI
10.1186/s12943-022-01598-6
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82002989, 81972386, 81972394]; Special Project of Medical Innovation Team in Jiangsu Province [CXTDA2017047]; Major Project of Jiangsu Commission of Health [ZD2021002]; Wuxi Taihu Lake Talent Plan [THRCJH20200406, THRCJH20200104, LCZX2021003, N20192002]; Guangdong Basic and Applied Basic Research Foundation [2020A1515010066, 2022A1515010437]; President Foundation of The Third Affiliated Hospital of Southern Medical University [YM2021011, YM2021010]

作者

  • Y

    Yao, Bing (第一作者)

    2 · nanjing med univ

  • Z

    Zhu, Sha

    2 · nanjing med univ

查看全部 16 位作者收起作者
  • W

    Wei, Xiyi

    1 · nanjing med univ

  • C

    Chen, Ming-Kun

    southern med univ

  • F

    Feng, Yangkun

    nantong univ

  • L

    Li, Zhimin

    southern med univ

  • X

    Xu, Xinyu

    2 · nanjing med univ

  • Z

    Zhang, Yuwei

    2 · nanjing med univ

  • W

    Wang, Yang

    2 · nanjing med univ

  • Z

    Zhou, Jingwan

    2 · nanjing med univ

  • T

    Tang, Ningyuan

    2 · nanjing med univ

  • J

    Ji, Chengjian

    1 · nanjing med univ

  • J

    Jiang, Peng

    2 · nanjing med univ

  • Z

    Zhao, Shan-Chao (通讯)

    southern med univ

  • Q

    Qin, Chao (通讯)

    1 · nanjing med univ

  • F

    Feng, Ninghan (通讯)

    nantong univ · 2 · nanjing med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417